WO2002074329A1 - Pharmaceutical composition applied to the treatment of the peyronie disease and corresponding obtention process - Google Patents

Pharmaceutical composition applied to the treatment of the peyronie disease and corresponding obtention process Download PDF

Info

Publication number
WO2002074329A1
WO2002074329A1 PCT/BR2001/000027 BR0100027W WO02074329A1 WO 2002074329 A1 WO2002074329 A1 WO 2002074329A1 BR 0100027 W BR0100027 W BR 0100027W WO 02074329 A1 WO02074329 A1 WO 02074329A1
Authority
WO
WIPO (PCT)
Prior art keywords
epitheliums
permeability
pharmaceutical composition
coating
epithelium
Prior art date
Application number
PCT/BR2001/000027
Other languages
French (fr)
Inventor
Cristiano Alberto Ribeiro Santana
Marcio Falci
Gilberto De Nucci
Original Assignee
Ribeiro Santana Cristiano Albe
Marcio Falci
Gilberto De Nucci
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribeiro Santana Cristiano Albe, Marcio Falci, Gilberto De Nucci filed Critical Ribeiro Santana Cristiano Albe
Priority to PCT/BR2001/000027 priority Critical patent/WO2002074329A1/en
Publication of WO2002074329A1 publication Critical patent/WO2002074329A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases

Definitions

  • the present invention refers to a new pharmaceutical composition, to be used in any pharmaceutical form, most notably gel, cream and cream gel, liquid, spray, aerosol, lyophilized used for treating the Peyronie disease and based on bromeline, as well as its process of obtention.
  • the above mentioned pharmaceutical composition is of topical application, non-toxic, featuring debridant and anti- inflammatory action with a high penetration rate through the skin.
  • the skin permeability varies according to the region of the body, being the skin folds and the face those that present the highest absorption rate. A product applied over the skin will present a longer period of contact and percutanial absorption.
  • the epithelium cells are predominantly classified into two categories, which correspond to two epithelium classes: coating epithelium cells and secreting epithelium cells.
  • the cells of these two classes mix with each other to constitute, respectively, the coating epithelium and the secreting epithelium, each one of them performing specific functions that are inherent to them. Such division is also fundamented in the distribution of these two classes of epithelium in the organism, which although wide is distinctive for both.
  • the epithelium cells associate side-by-side, so as to originate "membranes” or layers superimposed over the base membrane, which function is to coat surfaces.
  • the secreting cells unite to form organized functional units, better suited for performing their specialized function, related to the secretion products synthesis; thus are constituted the secreting units .
  • the coating epitheliums are defined as living membranes, usually featuring a discontinuity, that isolate the organism from the environment, separating the internal media from the external one. Furthermore, these epitheliums isolate from each other the various internal media compartments, among which are the intravascular compartment, the serum compartment and several others.
  • various functions performed by the coating epitheliums some are performed by specialized variants that are specifically adapted to perform one or more functions. Others are incorporated as general functions presented without distinction by every coating epithelium cell.
  • the coating epithelium cell in the same way as most of the living cells, passively absorbs water and electrolytes and eliminates them actively; this function is well " developed n the epithelium cells.
  • the coating epitheliums although continuously covering and protecting those surfaces it coats, are not impervious at all; that is why they do not behave as inert "membranes". On the contrary, they allow for the exchange of gases, water, several kinds of electrolytes and certain other solutes between the internal and the external media, or between the various internal compartments, which characterizes its permeability.
  • the coating epithelium cells limit in a controlled and selective way the permeability of the respective epitheliums, with the purpose of protecting the organism and still participate of the control of its homeostasis.
  • the epitheliums are organized and arrange their cells in a special form, in order to build up coatings which cells abut the base membrane and are united with each other by means of intracellular junctions; in turn the cells are coated by the plasmatic membrane, which features special characteristics, and by the glicochalice, both able to express well defined functional properties.
  • the functional characteristics expressed by the plasmatic membrane portion that coats the cells apical surface are different from those expressed by the portion situated in its basal or basolateral face; such differences, which occur mainly on the functional aspect, contribute for the remarkable degree of polarization expressed by the coating epithelium cells.
  • the prime function performed by the coating epitheliums correspond essentially to the protection rendered to the surface that they coat, characterizing their protective coating function.
  • Such function features a special characteristic, being a coating that, besides offering mechanical, physical and chemical protection to the coated surface, is not inert.
  • the coating epitheliums are pervious, which allows for the controlled and selective passage of several products through its wall.
  • the coating epitheliums permeability constitutes a fundamental property, with significant functional expression, for it is essential for the performance of several functions featured by the epitheliums, even more so because it is selective and its permeability degree presents a wide variation. It is fairly well demonstrated that the permeability degree influences strongly the function performed by the coating epitheliums :
  • these coating epitheliums present selective permeability, which allows them to interfere and qualitatively control their functional activity, as well as making them more able to ' actuate over the homeostasis control.
  • the absence of epithelium permeability is correlated to the complex isolation of the coated surface and, on the other hand, to the better controlling of this epithelium function, because its cells, although very poorly pervious, present selective permeability.
  • the coated surface has its boundaries limited by a "membrane" impervious or very poorly pervious and very effective, that performs an important protective function, for it is able to discriminate exactly what can cross the epithelium.
  • the coating epitheliums permeability is such an expressive functional property that it has been used as an important classification criterion to rank them in three classes:
  • the continuity of the epithelium coating is established as much through the intimate abutment of adjacent cells as through the presence of intercellular union devices.
  • the epithelium cells are enveloped by the glicochalice, that also takes part of the coating function performed by the epithelium, in addition to aid the union between adjacent cells, because the intracellular adhesive is formed also by the glicochalice.
  • glicochalice that also takes part of the coating function performed by the epithelium, in addition to aid the union between adjacent cells, because the intracellular adhesive is formed also by the glicochalice.
  • the first four derive mostly from the epithelium cells selective permeability, over which are additionally superimposed the additional affects corresponding to their properties of absorption, excretion and secretion.
  • the selective permeability is responsible by the efficiency regarding the ability to coat, protect and isolate the surfaces, as well as to effect the control of the homeostasis; the passive absorption and the metabolytes transfer capacity are executed normally by the majority of the cells of these epitheliums, which demand only minor adaptations to become able to effectively perform such functions.
  • the functions of absorption, excretion and secretion depend of properties that develop successively and would become paramount, mostly in some specialized types of coating epithelium, which adapted following a new and specific direction.
  • the sensorial perception and the germinative function are more specific functions that are only manifest by certain epitheliums even more specialized.
  • the coating epitheliums have been classified according to the same number of cellular extracts they bear in: simple (a single extract) and stratified (two or more extracts) . Both the simple epitheliums and the stratified ones, conforming to their cells format, are in turn subdivided into pavimentous, cubic or prismatic.
  • the simple epitheliums are usually adapted to manifest wholly their most expressive fundamental property that consists in their permeability, which degree and selectivity vary.
  • the simple coating epitheliums constituted by a single layer of pavimentous or cubic-prismatic cells, present major differences regarding their functional properties, correlated not only to their cell's morphology, but also to the intracellular space's properties.
  • the simple pavimentous epitheliums are usually very pervious; the cubic-prismatic ones are less pervious.
  • the coating epitheliums permeability, in addition to being selective, is controlled by their cell's functional activity, although the control looses efficiency in the same order as the intracellular space's permeability increases.
  • the cubic-prismatic epitheliums being less pervious than the pavimentous, are more effective to control their permeability.
  • the simple coating epitheliums are divided into two classes: pavimentous and cubic-prismatic . Each class is subdivided according to its functional properties in open or pervious epitheliums, in semi-occlusive or poorly-pervious and occlusive or impervious.
  • the cubic epitheliums and the prismatic epitheliums are usually considered distinct, being defined and identified according to the format of the epithelium cells that make them up.
  • some functional studies have showed that the correlation between form and function presents several exceptions. For this reason a functional classification is adopted considering predominantly it's permeability.
  • these epitheliums are denominated cubic-prismatic comprising the semi-occlusive and occlusive epitheliums.
  • the stratified epitheliums can be subdivided into: pavimentous and cubic- prismatic.
  • the stratified epitheliums are adapted to perform primarily the mechanical protection function, because they are impervious or poorly pervious.
  • the epitheliums comprise, in addition to the cells, the intercellular space and the base membrane, which interfere in their permeability degree; their permeability derives not only from their cell's peculiar properties, responsible for the transcellular permeability way, but also from the presence of another permeability way of their walls, constituting the intercellular or paracellular way.
  • the transcellular way comprises two different ways that consist of the transmembranous way and the transcannular or trancitose way.
  • the coating epitheliums can be transposed by water and by substances of various natures, both through their epithelium cells (transcellular way) and through the way situated between their cells (intercellular way) .
  • the epithelium cell can effect the permeability control of the epithelium through its biological activity, making this process selective.
  • the intercellular way permeability the epithelium cell, although not behaving in a totally passive form, does not interfere directly in the transport selectivity.
  • the sole form of cell active participation comprises the determination, exceptionally, the enlargement of the corresponding intercellular space.
  • the epithelium cell By means of the action of the microfilaments that constitute its cito-skeleton, the epithelium cell, specially those of certain types of simple coating epitheliums pavimentous of the open type, can change its format and retract segments of its cytoplasm; thus being able to influence the size of the intercellular space and regulate it. It has been established that the transcellular permeability of the simple coating epitheliums is perfectly distinct from the intercellular permeability, because both are subordinated to very different mechanisms. The epithelium cell permeability, which is selective, is influenced by its biological activity; on the contrary, the intercellular permeability is totally passive, and thus is not selective.
  • the transcellular permeability of the simple coating epitheliums can be exercised through two distinct and independent ways: the transmembrane way, which is the true transcellular way, and the transcannular way, which happens through the vesicles and the cannules or tubes of the vesicle-cannular system, found inside the cytoplasm of many types of , coating epithelium cells". Consequently, the coating epitheliums are pervious, which allows the controlled and selective passage of various products through its wall. It is demonstrated that the permeability degree affects strongly the coating epitheliums function.
  • the purpose is to prove through the formulation that there is an intense metabolic exchange demonstrating that the epithelium actuates on the transfer of metabolytes . This penetration of substances is complete and gradual and trespasses these epithelium layers until it penetrates the small blood vessels, reaching the circulatory current .
  • Bromeline is the generic name given to the protheolitic enzymes found on pineapple (Ananas comosus Mer. ) , as well as in other species of plants from the family Bromeliaceae .
  • the bromelines hydrolyze proteins, peptides, esters and amides. Its specificity and use are relatively similar to that of other proteases, such as papaine and fycine, extracted from latex of papaya and fig, respectively.
  • Bromeline is also similar to papaine when it comes to its activation and deactivation mechanism as a sulphidrilyc protease, that is, its enzymatic action depends on the sulphidrilyc group of a cisteyne residue.
  • the presence of an enzyme with strong protheolytic activity in the fresh pineapple juice has been known for a long time. Although the activity decreases significantly in the ripening, the levels are reasonably high in the juice extracted from the partially ripened fruit usually used in the processing.
  • Pineapple is the only fruit that features relatively high concentrations of proteases in the ripe state. In papaya, the papaine is only found in high levels when the fruit is still green.
  • raw material for the obtention of bromeline different parts of the plant can be used: leaves, stems, fruit juice, skin and industrial residues.
  • the most commonly used raw material is the ripe pineapple plant stems, used after the harvesting of the fruit. This raw material is easily available thanks to the plantation turnover .
  • the bioequivalence examination was carried out for the substance bromeline, resulting in parity from 1% to 1% between bromeline and papaine.
  • PEYRONIE DISEASE The Peyronie disease has been known to medical science for over 200 years and, more particularly, is most widely known in the area of urology.
  • the animals were treated and anesthetized for the corresponding procedures and the histological cuts were analyzed under a common optical microscope and the results were submitted to a comparative analysis of both groups according to the formation date of fibroblasts and collagen fibers .
  • protheolytic refers to the involvement of proteases (chemiotripcyne and catepcine) and on the collagenase which, currently, not only makes easier the destruction of foreign bodies, but also hydrolyzes the collagen, whose resulting peptides act as a chemotheraphic substance stimulating the proliferation of fibroblasts .
  • proteases chemiotripcyne and catepcine
  • composition materials which, in a period ranging from 8 to 12 months was applied directly on the penis, consisting of: application of the present formulation, during 30 minutes without removal of the same in order to ensure the penetration; this application was conducted in the dorsal and lateral areas up to the pendulum area, with no need of application on the gland.
  • the applicant created the present cream composition applied to the treatment of the Peyronie disease which activated the action of the protheolityc enzymes with debridant and anti-inflammatory activities in the healing of fibrous lesions.
  • microcirculatory unit qualified as rotative plate of the cellular life, is a center of equilibrium of tissues, therefore the various vascular systems must adapt to the circulatory variations .
  • the venous stasis causes an increase in the intracapillar pressure. It generates an increase in the capillar permeability, which translates into the outflow of liquids and proteins of high molecular weight towards the conjunctive tissue.
  • the excess of permeability and the interstitial flooding originate a lymphatic overload, which causes an edema.
  • the liberation of aggressive substances, such as histamine, serotonine and prostaglandines unchain a series of tissue reactions. If the protein excesses are not depolymerized by the macrophages, there occurs a fibroblasts stimulation and the installation of fibrosis, which in turn keeps and makes worse the a venocapillar-limphatic stasis closing down the pathologic circle.
  • the object of the present invention is a new
  • composition comprises the following formulation:
  • composition may comprise in its formulation:
  • HYALURONIDASE 50 to 900utr/mg More particularly said composition may comprise in its formulation: BROMELINE more than 0.1%
  • the pharmaceutical composition at hand may present itself in the form of gel, cream gel, aerosol or spray .
  • the process of production of the pharmaceutical composition comprises the steps of: - heating the oil and aqueous phases up to a temperature ranging from 40 to 90 2 C;
  • Bromeline can advantageously be used in the formulation of said composition, in the range of 0.5 to 5%.
  • the pharmaceutical composition of the present invention is used in several different pathologies . Particularly it is used to treat the Peyronie disease.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention refers to a pharmaceutical composition applied to treat the Peyronie disease and its corresponding obtention process. The composition comprises in its formulation bromeline and eventually, vitamin-E and/or hyaluronidase.

Description

"PHARMACEUTICAL COMPOSITION APPLIED TO THE
TREATMENT OF THE PEYRONIE DISEASE AND CORRESPONDING OBTENTION
PROCESS" .
TECHNICAL FIELD: The present invention refers to a new pharmaceutical composition, to be used in any pharmaceutical form, most notably gel, cream and cream gel, liquid, spray, aerosol, lyophilized used for treating the Peyronie disease and based on bromeline, as well as its process of obtention. The above mentioned pharmaceutical composition is of topical application, non-toxic, featuring debridant and anti- inflammatory action with a high penetration rate through the skin.
BRIEF DESCRIPTION OF THE INVENTION The skin permeability varies according to the region of the body, being the skin folds and the face those that present the highest absorption rate. A product applied over the skin will present a longer period of contact and percutanial absorption. According to the classic book "Histologia dos epitelios", by Walter A. Hadler 'and Sineli R. Silveira, Editora Campus, Campinas, 1993, it is considered that: "bearing in mind the general morphological characteristics and the specialized functions that they perform, the epithelium cells are predominantly classified into two categories, which correspond to two epithelium classes: coating epithelium cells and secreting epithelium cells. The cells of these two classes mix with each other to constitute, respectively, the coating epithelium and the secreting epithelium, each one of them performing specific functions that are inherent to them. Such division is also fundamented in the distribution of these two classes of epithelium in the organism, which although wide is distinctive for both. With the purpose of forming the coating epitheliums the epithelium cells associate side-by-side, so as to originate "membranes" or layers superimposed over the base membrane, which function is to coat surfaces. On the contrary, the secreting cells unite to form organized functional units, better suited for performing their specialized function, related to the secretion products synthesis; thus are constituted the secreting units . The coating epitheliums are defined as living membranes, usually featuring a discontinuity, that isolate the organism from the environment, separating the internal media from the external one. Furthermore, these epitheliums isolate from each other the various internal media compartments, among which are the intravascular compartment, the serum compartment and several others. Among the various functions performed by the coating epitheliums some are performed by specialized variants that are specifically adapted to perform one or more functions. Others are incorporated as general functions presented without distinction by every coating epithelium cell. The coating epithelium cell, in the same way as most of the living cells, passively absorbs water and electrolytes and eliminates them actively; this function is well" developed n the epithelium cells. On that account it is very important to observe that generally it is understood as absorption the penetration of solutions through the cells plasmatic membrane. However two different specific forms of absorption must be distinguished from one another: the passive absorption, that occurs according to the osmotic laws, and the active absorption, that entails the effective participation of the epithelium cell and that does not follow such physic laws. On the other hand it must be considered that every single substance that penetrates the interior of a multi-cellular organism, or else is excreted or eliminated, must cross at least one coating epithelium, because every superior organism is penetrated internally and externally by epitheliums . It must also be observed that the coating epitheliums, although continuously covering and protecting those surfaces it coats, are not impervious at all; that is why they do not behave as inert "membranes". On the contrary, they allow for the exchange of gases, water, several kinds of electrolytes and certain other solutes between the internal and the external media, or between the various internal compartments, which characterizes its permeability. The coating epithelium cells limit in a controlled and selective way the permeability of the respective epitheliums, with the purpose of protecting the organism and still participate of the control of its homeostasis. In order to perform such function the epitheliums are organized and arrange their cells in a special form, in order to build up coatings which cells abut the base membrane and are united with each other by means of intracellular junctions; in turn the cells are coated by the plasmatic membrane, which features special characteristics, and by the glicochalice, both able to express well defined functional properties. The functional characteristics expressed by the plasmatic membrane portion that coats the cells apical surface are different from those expressed by the portion situated in its basal or basolateral face; such differences, which occur mainly on the functional aspect, contribute for the remarkable degree of polarization expressed by the coating epithelium cells. The prime function performed by the coating epitheliums correspond essentially to the protection rendered to the surface that they coat, characterizing their protective coating function. Such function features a special characteristic, being a coating that, besides offering mechanical, physical and chemical protection to the coated surface, is not inert. The coating epitheliums are pervious, which allows for the controlled and selective passage of several products through its wall. There are many evidences in favor of the idea that the coating epitheliums permeability constitutes a fundamental property, with significant functional expression, for it is essential for the performance of several functions featured by the epitheliums, even more so because it is selective and its permeability degree presents a wide variation. It is fairly well demonstrated that the permeability degree influences strongly the function performed by the coating epitheliums :
1) wide permeability;
2) reduced permeability and
3) absence of permeability. When there is a wide permeability, the epitheliums allow intense metabolic exchanges through their walls, with poor control and selectivity of its permeability. In these circumstances the epithelium acts on the filtration and transfer of metabolytes, these functions requiring little qualitative control; the exercise of these functions is subordinated to the epithelium intrinsic structure, which is adapted to act, mainly passively, being low the level of selective permeability. The coating epitheliums with a reduced degree of permeability, due to the characteristic that is so peculiar to them, present the property of partially controlling their own permeability, and above all their selectivity. As a consequence, these coating epitheliums present selective permeability, which allows them to interfere and qualitatively control their functional activity, as well as making them more able to ' actuate over the homeostasis control. The absence of epithelium permeability is correlated to the complex isolation of the coated surface and, on the other hand, to the better controlling of this epithelium function, because its cells, although very poorly pervious, present selective permeability. In this case the coated surface has its boundaries limited by a "membrane" impervious or very poorly pervious and very effective, that performs an important protective function, for it is able to discriminate exactly what can cross the epithelium. The coating epitheliums permeability is such an expressive functional property that it has been used as an important classification criterion to rank them in three classes:
1) pervious epitheliums;
2) poorly pervious epitheliums and
3) impervious epitheliums. Because of their selective permeability, even in the inferior animals the epitheliums have assumed the function of coating the organism, constituting its external coating, with limiting and protective properties, not only morphological but also functional. Their cells, in principle very similar, behaved as a semi-pervious "membrane" poorly effective that acted' passively, but which function allowed the separation, tough precarious and more morphological than functional, between the internal and the external media. It seem to be that the majority of the coating epitheliums acts as a barrier that prevents the free passive diffusion, because their permeability, which is selective, is conditioned to several factors among which stands out the electric potential present in their cells plasmatic membrane. The continuity of the epithelium coating is established as much through the intimate abutment of adjacent cells as through the presence of intercellular union devices. The epithelium cells are enveloped by the glicochalice, that also takes part of the coating function performed by the epithelium, in addition to aid the union between adjacent cells, because the intracellular adhesive is formed also by the glicochalice. Several experimental investigations confirm that the coating epitheliums selective permeability is associated to other specific functions expressed by their cells, namely: absorption, excretion and secretion. These functions, beyond their permeability, which constitutes their prime function, are responsible by the general functioning of the epithelium cell. The general functions performed by the coating epitheliums are basically the following:
1) surfaces protective coating function;
2) isolation and functional individualization of the internal media and of its distinct compartments, due to their cells selective permeability;
3) controlling the homeostasis of the internal medium and its compartments due to their cells ability to interfere in the epithelium selective permeability; the epithelium cells manifest the capacity to effect the absorption, secretion and excretion; such functions interfere on the epithelium permeability;
4) performance of the metabolic functions due to their ability to effect hydrosalinic exchanges and to effect metabolytes transfers 'due to their cells and intracellular spaces high degree of poorly selective permeability;
5) transport of products along the epithelial surface due to the participation of the cilia;
6) sensorial perception and
7) germinative function.
Among these functions, the first four derive mostly from the epithelium cells selective permeability, over which are additionally superimposed the additional affects corresponding to their properties of absorption, excretion and secretion. Among the general functions performed by the coating epitheliums, the selective permeability is responsible by the efficiency regarding the ability to coat, protect and isolate the surfaces, as well as to effect the control of the homeostasis; the passive absorption and the metabolytes transfer capacity are executed normally by the majority of the cells of these epitheliums, which demand only minor adaptations to become able to effectively perform such functions. On the contrary, the functions of absorption, excretion and secretion depend of properties that develop successively and would become paramount, mostly in some specialized types of coating epithelium, which adapted following a new and specific direction. The sensorial perception and the germinative function are more specific functions that are only manifest by certain epitheliums even more specialized. Considering their cell's morphological characteristics, the coating epitheliums have been classified according to the same number of cellular extracts they bear in: simple (a single extract) and stratified (two or more extracts) . Both the simple epitheliums and the stratified ones, conforming to their cells format, are in turn subdivided into pavimentous, cubic or prismatic. The simple epitheliums are usually adapted to manifest wholly their most expressive fundamental property that consists in their permeability, which degree and selectivity vary. The simple coating epitheliums, constituted by a single layer of pavimentous or cubic-prismatic cells, present major differences regarding their functional properties, correlated not only to their cell's morphology, but also to the intracellular space's properties. The simple pavimentous epitheliums are usually very pervious; the cubic-prismatic ones are less pervious. The coating epitheliums permeability, in addition to being selective, is controlled by their cell's functional activity, although the control looses efficiency in the same order as the intracellular space's permeability increases. The cubic-prismatic epitheliums, being less pervious than the pavimentous, are more effective to control their permeability. Based on the format of the epithelium cell, in its permeability and the coating epitheliums most common adaptations, it is possible to generate a provisional classification for these epitheliums. Thus, the simple coating epitheliums are divided into two classes: pavimentous and cubic-prismatic . Each class is subdivided according to its functional properties in open or pervious epitheliums, in semi-occlusive or poorly-pervious and occlusive or impervious. In the simple coating epitheliums classification, the cubic epitheliums and the prismatic epitheliums are usually considered distinct, being defined and identified according to the format of the epithelium cells that make them up. However some functional studies have showed that the correlation between form and function presents several exceptions. For this reason a functional classification is adopted considering predominantly it's permeability. According to this criterion these epitheliums are denominated cubic-prismatic comprising the semi-occlusive and occlusive epitheliums. Following the same criterion the stratified epitheliums can be subdivided into: pavimentous and cubic- prismatic. The stratified epitheliums are adapted to perform primarily the mechanical protection function, because they are impervious or poorly pervious. The epitheliums comprise, in addition to the cells, the intercellular space and the base membrane, which interfere in their permeability degree; their permeability derives not only from their cell's peculiar properties, responsible for the transcellular permeability way, but also from the presence of another permeability way of their walls, constituting the intercellular or paracellular way. The transcellular way comprises two different ways that consist of the transmembranous way and the transcannular or trancitose way. It has been demonstrated, experimentally, that the coating epitheliums can be transposed by water and by substances of various natures, both through their epithelium cells (transcellular way) and through the way situated between their cells (intercellular way) . In the first instance the epithelium cell can effect the permeability control of the epithelium through its biological activity, making this process selective. As for the intercellular way permeability, the epithelium cell, although not behaving in a totally passive form, does not interfere directly in the transport selectivity. The sole form of cell active participation, in this instance, comprises the determination, exceptionally, the enlargement of the corresponding intercellular space. By means of the action of the microfilaments that constitute its cito-skeleton, the epithelium cell, specially those of certain types of simple coating epitheliums pavimentous of the open type, can change its format and retract segments of its cytoplasm; thus being able to influence the size of the intercellular space and regulate it. It has been established that the transcellular permeability of the simple coating epitheliums is perfectly distinct from the intercellular permeability, because both are subordinated to very different mechanisms. The epithelium cell permeability, which is selective, is influenced by its biological activity; on the contrary, the intercellular permeability is totally passive, and thus is not selective. Several experimental results have confirmed that the transposition of solutions through the epitheliums is subject to multiple control mechanisms, among which is paramount the intrinsic functional activity of its cells. On the contrary, the intercellular space permeability is generally not controlled, because in this case the transposition of a molecule through the epithelium follows only the corresponding physical laws and is directly related to its diameter, its electrical cargo and, obviously, to the intercellular space size; these three variables constitute the main limiting factors that interfere on the intercellular permeability of the simple coating epitheliums. The transcellular permeability of the simple coating epitheliums can be exercised through two distinct and independent ways: the transmembrane way, which is the true transcellular way, and the transcannular way, which happens through the vesicles and the cannules or tubes of the vesicle-cannular system, found inside the cytoplasm of many types of , coating epithelium cells". Consequently, the coating epitheliums are pervious, which allows the controlled and selective passage of various products through its wall. It is demonstrated that the permeability degree affects strongly the coating epitheliums function.
Three types of coating epitheliums are thus considered:
1- Of wide permeability; 2- Of reduced permeability;
3- Of null permeability.
The purpose is to prove through the formulation that there is an intense metabolic exchange demonstrating that the epithelium actuates on the transfer of metabolytes . This penetration of substances is complete and gradual and trespasses these epithelium layers until it penetrates the small blood vessels, reaching the circulatory current .
There is a description of the molecules to estimate the coating epitheliums permeability. Ex. : Hemoglobin, Ferritin, Lipoproteins and enzymes. It is also known the transcitose on the transposition of the epitheliums by the macro and micro molecules until the vascular eye depending of their association.
Bromeline is the generic name given to the protheolitic enzymes found on pineapple (Ananas comosus Mer. ) , as well as in other species of plants from the family Bromeliaceae . The bromelines hydrolyze proteins, peptides, esters and amides. Its specificity and use are relatively similar to that of other proteases, such as papaine and fycine, extracted from latex of papaya and fig, respectively.
Bromeline is also similar to papaine when it comes to its activation and deactivation mechanism as a sulphidrilyc protease, that is, its enzymatic action depends on the sulphidrilyc group of a cisteyne residue. The presence of an enzyme with strong protheolytic activity in the fresh pineapple juice has been known for a long time. Although the activity decreases significantly in the ripening, the levels are reasonably high in the juice extracted from the partially ripened fruit usually used in the processing.
Pineapple is the only fruit that features relatively high concentrations of proteases in the ripe state. In papaya, the papaine is only found in high levels when the fruit is still green.
As raw material for the obtention of bromeline different parts of the plant can be used: leaves, stems, fruit juice, skin and industrial residues. However, the most commonly used raw material is the ripe pineapple plant stems, used after the harvesting of the fruit. This raw material is easily available thanks to the plantation turnover . The bioequivalence examination was carried out for the substance bromeline, resulting in parity from 1% to 1% between bromeline and papaine.
PEYRONIE DISEASE The Peyronie disease has been known to medical science for over 200 years and, more particularly, is most widely known in the area of urology.
Through studies effected by the applicant of the present invention, among which should de highlighted some experimental works rarely carried out on animals, which evaluate the histologic and monometric aspects of tissue healing by means of the application of the present invention's composition with the use of papaine. These studies used 40 adult rats (rattus norvegicus albinus) , which were kept in isolated cages with food and water. The animals were distributed in two groups of 20 animals each, according to the type of treatment, which means, a group of 20 animals to which no treatment whatsoever was applied and another group of 20 animals that were treated with the solution of papaine at 2% in topical use over the wound.
The animals were treated and anesthetized for the corresponding procedures and the histological cuts were analyzed under a common optical microscope and the results were submitted to a comparative analysis of both groups according to the formation date of fibroblasts and collagen fibers .
Other studies were carried out, where, for example, 24 men were studied in 63 analyzed cases, with ages varying from 41 to 72 years, all the men being of the white color and presenting diverse degrees of manifestation of the
Peyronie disease, divided into three groups of manifestation:
I — Fibrosis in a small distinct area of the penis without curvature deviation;
II — Longitudinal fibrosis or in a circumscribed area featuring penis deviation; (curvature) :
III — Fibrosis with calcified plaques with upstream deviation of the penis . The patients of group 1 had complete remission of the symptoms.
The patients of group II yielded the following results: 60% complete remission of the lesion, 20% partial remission and 20% did not feature any improvement. These studies were evaluated, and the conclusion was that in the inflammatory process there are several factors implied, being the most prominent: vascular swelling with exudation; migration of leukocytes and macrophages ; proliferation of fibroblasts; action of chemical mediators such as histamine, serotonine, bradicinine and prostaglandines; protheolytic activity. Regarding the protheolytic' activity, it refers to the involvement of proteases (chemiotripcyne and catepcine) and on the collagenase which, currently, not only makes easier the destruction of foreign bodies, but also hydrolyzes the collagen, whose resulting peptides act as a chemotheraphic substance stimulating the proliferation of fibroblasts .
The observation of wounds treated with papaine shows that the granulation tissue is better developed with a higher number of fibroblasts and collagenous fibers, given the fact that the papaine may inclusively aid the digestion of the denatured collagen. Based on the observations of this experiment the papaine solution acted just like the other proteases, or in other words, digesting tissue residues of protein nature that resulted in peptides, which are chemotactic for the fibroblasts, stimulating the early fiberplasy in the group treated with 2% papaine solution promoting a more effective tissue healing in the superficial and deep regions of wounds with fibrosis and keloids, thus being an effective alternative, non-invasive for the treatment of the Peyronie disease.
This way, in order to obtain the results indicated hereinabove, the applicant developed through the composition materials a therapeutic method which, in a period ranging from 8 to 12 months was applied directly on the penis, consisting of: application of the present formulation, during 30 minutes without removal of the same in order to ensure the penetration; this application was conducted in the dorsal and lateral areas up to the pendulum area, with no need of application on the gland.
Thus, aiming to obtain a formulation of topical use, featuring a high degree of penetration through the skin, and that provedly obtains an improvement of 80% to 86% of the disease manifestation, the applicant created the present cream composition applied to the treatment of the Peyronie disease which activated the action of the protheolityc enzymes with debridant and anti-inflammatory activities in the healing of fibrous lesions.
MICROCIRCULATORY UNIT
The microcirculatory unit, qualified as rotative plate of the cellular life, is a center of equilibrium of tissues, therefore the various vascular systems must adapt to the circulatory variations .
When the venous perturbation compensation mechanisms are overcome, the vascular and tissue structures change .
The venous stasis causes an increase in the intracapillar pressure. It generates an increase in the capillar permeability, which translates into the outflow of liquids and proteins of high molecular weight towards the conjunctive tissue.
The excess of permeability and the interstitial flooding originate a lymphatic overload, which causes an edema. The liberation of aggressive substances, such as histamine, serotonine and prostaglandines unchain a series of tissue reactions. If the protein excesses are not depolymerized by the macrophages, there occurs a fibroblasts stimulation and the installation of fibrosis, which in turn keeps and makes worse the a venocapillar-limphatic stasis closing down the pathologic circle.
The object of the present invention is a new
"PHARMACEUTICAL COMPOSITION APPLIED TO THE TREATMENT OF THE
PEYRONIE DISEASE", wherein said composition comprises the following formulation:
BROMELINE more than 0.1%
Particularly said composition may comprise in its formulation:
BROMELINE more than 0.1% VITAMIN-E 10 to 2000mg
Advantageously said composition comprises in its formulation:
BROMELINE more than 0.1%
HYALURONIDASE 50 to 900utr/mg More particularly said composition may comprise in its formulation: BROMELINE more than 0.1%
VITAMIN-E 10 to 2000mg
HYALURONIDASE 50 to 00utr/mg. The pharmaceutical composition at hand may present itself in the form of gel, cream gel, aerosol or spray .
The process of production of the pharmaceutical composition comprises the steps of: - heating the oil and aqueous phases up to a temperature ranging from 40 to 902C;
- Incorporating oil to the water;
- letting it reach the room temperature;
- Add bromeline, vitamin-E and hyaluronidase; - Homogenize
Bromeline can advantageously be used in the formulation of said composition, in the range of 0.5 to 5%.
The pharmaceutical composition of the present invention is used in several different pathologies . Particularly it is used to treat the Peyronie disease.

Claims

C L A I M S
1) "PHARMACEUTICAL COMPOSITION APPLIED TO THE TREATMENT OF THE PEYRONIE DISEASE" characterized by the fact of comprising in its formulation: BROMELINE more than
0.1%.
2) "PHARMACEUTICAL COMPOSITION" according to claim 1, characterized by the fact of comprising in its formulation: BROMELINE from 0.5% to
5%.
3) "PHARMACEUTICAL COMPOSITION" according to claim 1, characterized by the fact of comprising in its formulation: BROMELINE more than 0.1%
VITAMIN-E 10 to 2000mg.
4) "PHARMACEUTICAL COMPOSITION" according to claim 1, characterized by the fact of comprising in its formulation: BROMELINE more than 0.1%
HYALURONIDASE 50 to
900utr/mg.
5) "PHARMACEUTICAL COMPOSITION" according to claim 1, characterized by the fact of comprising in its formulation: :
BROMELINE more than 0.1%
VITAMIN-E 10 to 2000mg HYALURONIDASE 50 to
900utr/mg.
6) "OBTENTION PROCESS OF THE PHARMACEUTICAL COMPOSITION APPLIED TO THE TREATMENT OF THE PEYRONIE DISEASE" defined on claims 1 to 5, characterized by the fact of comprising the steps of: a) Heating of the oil and aqueous phases to a temperature in the range of 40 and 90 aC; b) Incorporation of the oil phase to the aqueous phase; c) Stirring until it reaches the room temperature ; d) Add bromeline and whenever necessary, vitamin-E and hyaluronidase; and e) Homogenization.
7) "PHARMACEUTICAL COMPOSITION" according to claims 1 to 5 , characterized by the fact that it is used in several different pathologies, notably the Peyronie disease . 8) "PHARMACEUTICAL COMPOSITION" according to claims 1 to 5 , characterized by the fact that it can be presented in the form of gel, cream, cream gel, spray or aerosol .
PCT/BR2001/000027 2001-03-19 2001-03-19 Pharmaceutical composition applied to the treatment of the peyronie disease and corresponding obtention process WO2002074329A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/BR2001/000027 WO2002074329A1 (en) 2001-03-19 2001-03-19 Pharmaceutical composition applied to the treatment of the peyronie disease and corresponding obtention process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BR2001/000027 WO2002074329A1 (en) 2001-03-19 2001-03-19 Pharmaceutical composition applied to the treatment of the peyronie disease and corresponding obtention process

Publications (1)

Publication Number Publication Date
WO2002074329A1 true WO2002074329A1 (en) 2002-09-26

Family

ID=3946483

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2001/000027 WO2002074329A1 (en) 2001-03-19 2001-03-19 Pharmaceutical composition applied to the treatment of the peyronie disease and corresponding obtention process

Country Status (1)

Country Link
WO (1) WO2002074329A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013011514A1 (en) 2011-07-20 2013-01-24 Mediwound Ltd. Proteolytic extract from bromelain for the treatment of connective tissue disorders

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008555A1 (en) * 1989-01-27 1990-08-09 Immunolytics, Inc. Composition and method for treating benign prostatic hypertrophy
BR9801985A (en) * 1998-04-30 2000-02-08 Cristiano Alberto Ribeiro Sant Creamy composition applied in the therapy of peyronie's disease.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008555A1 (en) * 1989-01-27 1990-08-09 Immunolytics, Inc. Composition and method for treating benign prostatic hypertrophy
BR9801985A (en) * 1998-04-30 2000-02-08 Cristiano Alberto Ribeiro Sant Creamy composition applied in the therapy of peyronie's disease.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200031, Derwent World Patents Index; AN 2000-351001 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013011514A1 (en) 2011-07-20 2013-01-24 Mediwound Ltd. Proteolytic extract from bromelain for the treatment of connective tissue disorders
CN103687607A (en) * 2011-07-20 2014-03-26 麦迪伍德有限公司 Proteolytic extract from bromelain for the treatment of connective tissue disorders
JP2014520881A (en) * 2011-07-20 2014-08-25 メディウンド リミテッド Bromelain derived proteolytic extract for the treatment of connective tissue disease
US9511126B2 (en) 2011-07-20 2016-12-06 Mediwound Ltd. Proteolytic extract from bromelain for the treatment of connective tissue disorders
AU2012285378B2 (en) * 2011-07-20 2017-03-02 Mediwound Ltd. Proteolytic extract from bromelain for the treatment of connective tissue disorders
CN103687607B (en) * 2011-07-20 2018-01-30 麦迪伍德有限公司 For treating the proteolysis extract from bromelain of connective tissue illness
KR101921363B1 (en) * 2011-07-20 2018-11-22 메디운드 리미티드 Proteolytic extract from bromelain for the treatment of connective tissue disorders
US10293033B2 (en) 2011-07-20 2019-05-21 Mediwound Ltd. Proteolytic extract from bromelain for the treatment of connective tissue disorders

Similar Documents

Publication Publication Date Title
AU2005305461B2 (en) Debriding composition from bromelain and methods of production thereof
Stefanov et al. Multifunctional enzymatically generated hydrogels for chronic wound application
EP2621520B1 (en) Collagenase g and collagenase h compositions for the treatment of diseases involving alterations of collagen
Vasconcelos et al. Papain immobilization on heterofunctional membrane bacterial cellulose as a potential strategy for the debridement of skin wounds
CN102670929A (en) Composite for injury healing and preparing method thereof
US4307081A (en) Enzyme mixture
EP1284750B1 (en) Pharmaceutical composition
WO2002074329A1 (en) Pharmaceutical composition applied to the treatment of the peyronie disease and corresponding obtention process
US20040146494A1 (en) Papaine containing pharmaceutical formulation resp its use
CN112608380A (en) Preparation method of collagen with molecular weight within certain range from pigskin
US20150297687A1 (en) Protease compositions for the treatment of damaged tissue
WO2000039290A2 (en) Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid
CA2492331A1 (en) Use of convertase inhibitors in the treatment of fibrosis and scarring
WO2001070258A1 (en) Pharmaceutical composition of carrier substance for products based on vitamin-e, bromeline and hyaluronidase
US20060233783A1 (en) Topical composition in the form of a gel for treating skin burns
JP2013221017A (en) Epidermal cell activator, cosmetic including the same, skin care external preparation and anti-wrinkle cosmetic
EP1553974A1 (en) Pharmaceutical composition comprising carriers for products
US20110045093A1 (en) Pharmaceutical composition and process comprising vegetable proteolytic enzymes in supramolecular nanoparticles, for the treatment of peyronie's disease, connective tissue diseases and use
KR102647642B1 (en) Peptides having blood coagulation activity and use thereof
WO2001054647A2 (en) Pharmaceutical composition comprising carriers for products based on vitamin-e, papain and hyaluronidase
Sajjad et al. The The Therapeutic Effects of Autologous Platelet-Rich Plasma Gel on Cutaneous Wound Healing in Rescued Horses: The Effects of Autologous Platelet-Rich Plasma Gel on skin Wound Healing in Horses
RU2268751C2 (en) Medical bandage containing proteolytic enzyme complex including collagenolytic proteases from crab hepatopancreas
Amid et al. Case study: Recombinant bromelain selection
O’Connell Additional therapeutic enzymes
US20080248021A1 (en) Use of Hyaluronidase in Combination with Plasmin for the Induction of Posterior Vitreous Detachment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA CN CZ HU ID IL IN IS JP KR MX NO NZ PL TR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP